Baheal Pharmaceutical Group Overview
- Founded
-
2005

- Status
-
Public
- Employees
-
2,642

- Stock Symbol
-
301015

- Share Price
-
$4.00
- (As of Monday Closing)
Baheal Pharmaceutical Group General Information
Description
Qingdao Baheal Medical Inc is engaged in providing comprehensive marketing services for pharmaceutical product manufacturers.
Contact Information
Primary Industry
Pharmaceuticals
Other Industries
Decision/Risk Analysis
Media and Information Services (B2B)
Other Financial Services
Stock Exchange
SHE
Primary Office
- 21th Floor, Building E1, Oriental Plaza
- No.1, East Changan Street, Dongcheng District
- Beijing
- China
+86 010 0000 0000
Baheal Pharmaceutical Group Stock Performance
(As of Monday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$4.00 | $3.91 | $2.89 - $4.50 | $2.1B | 525M | 2.55M | $0.15 |
Baheal Pharmaceutical Group Financials Summary
In Thousands, USD |
TTM 31-Mar-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 |
---|---|---|---|---|
EV | 2,078,083 | 1,834,316 | 2,501,267 | |
Revenue | 1,070,025 | 1,115,090 | 1,092,068 | 851,014 |
EBITDA | 110,146 | 115,128 | 102,313 | 70,676 |
Net Income | 78,319 | 74,554 | 65,299 | 39,474 |
Total Assets | 738,713 | 729,089 | 722,128 | 620,016 |
Total Debt | 193,334 | 193,889 | 192,388 | 214,263 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Baheal Pharmaceutical Group Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Baheal Pharmaceutical Group Executive Team (1)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Gang Fu | Chief Executive Officer |